Indications and uses
Helps prevent sunburn.
ESIKA PERFECT SKIN COVERAGE CONCEALER SPF 17
- Manufacturer
- Ventura Corporation LTD | Bel Star S.A. (Colombia)
- Effective date
- 2014-04-08
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:36:42
Label at a glance#
ProductESIKA PERFECT SKIN COVERAGE CONCEALER SPF 17 (Beige 1) - BEIGE
Active ingredientTitanium Dioxide
Label structure21 sections
Dosage and administration
Apply liberally and evenly 15 minutes before sun exposure. Reapply at least every 2 hours. Use a water resistant sunscreen if swimming or sweating. Children under 6 months of age: Ask a doctor
Storage and handling
Protect this product in this container form excesive heat and direct sun.
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
Active Ingredients
Titanium dioxide 4%
Purpose
Sunscreen
Uses
- Helps prevent sunburn.
Warnings
SPL UNCLASSIFIED SECTION
- Skin Cancer / Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging. Rinse with water to remove. If swallowed, get medical help or contact a Poison Control Center right away.
OTC - WHEN USING SECTION
- For external use only.
OTC - DO NOT USE SECTION
- Do not use on damaged or broken skin.
OTC - WHEN USING SECTION
- When using this product keep out of eyes.
OTC - STOP USE SECTION
- Stop use and ask a doctor if rash occurs.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
- Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Apply liberally and evenly 15 minutes before sun exposure.
- Reapply at least every 2 hours.
- Use a water resistant sunscreen if swimming or sweating.
- Children under 6 months of age: Ask a doctor
Other information
- Protect this product in this container form excesive heat and direct sun.
Inactive ingredients
Ethylhexyl palmitate, c12-15 alkyl benzoate, caprylic/capric triglyceride, mica, di-ppg-3 myristyl ether adipate, sorbitan isostearate, ozokerite, polyethylene, copernicia cerifera cera (carnauba) wax, polymethyl methacrylate, zea mays (corn) starch , beeswax, helianthus annuus seed oil (sunflower) seed oil, phenoxyethanol, calendula officinalis flower extract, methylparaben, dimethicone, fragrance, peg-40 hydrogenated castor oil, polysorbate 80, ppg-26-buteth-26, butylparaben, c9-13 fluoroalcohol, ethylparaben, hedera helix (ivy) leaf/stem extract, trimethylsiloxysilicate, retinyl palmitate, phosphoric acid, tocopheryl acetate, isobutylparaben, propylparaben, bioflavonoids, allantoin, ascorbyl palmitate. May contain: titanium dioxide, iron oxides, chitosan.
SPL UNCLASSIFIED SECTION
P.R.: Dist. by Ventura Corporation, Ltd. San Juan, Puerto Rico 00926.
PRINCIPAL DISPLAY PANEL - 2 g Carton - BEIGE 1
ēsika
PERFECT SKIN COVERAGE CONCEALER SPF 17
Net Weight 0.07 oz. (2 g)
PRINCIPAL DISPLAY PANEL - 2 g Carton - BEIGE 2
ēsika
PERFECT SKIN COVERAGE CONCEALER SPF 17
Net Weight 0.07 oz. (2 g)
PRINCIPAL DISPLAY PANEL - 2 g Carton - BEIGE 3
ēsika
PERFECT SKIN COVERAGE CONCEALER SPF 17
Net Weight 0.07 oz. (2 g)
PRINCIPAL DISPLAY PANEL - 2 g Carton - BEIGE 4
ēsika
PERFECT SKIN COVERAGE CONCEALER SPF 17
Net Weight 0.07 oz. (2 g)
PRINCIPAL DISPLAY PANEL - 2 g Carton - BEIGE 5
ēsika
PERFECT SKIN COVERAGE CONCEALER SPF 17
Net Weight 0.07 oz. (2 g)
PRINCIPAL DISPLAY PANEL - 2 g Carton - BEIGE 6
ēsika
PERFECT SKIN COVERAGE CONCEALER SPF 17
Net Weight 0.07 oz. (2 g)
PRINCIPAL DISPLAY PANEL - 2 g Carton - ROSA 1
ēsika
PERFECT SKIN COVERAGE CONCEALER SPF 17
Net Weight 0.07 oz. (2 g)
PRINCIPAL DISPLAY PANEL - 2 g Carton - ROSA 2
ēsika
PERFECT SKIN COVERAGE CONCEALER SPF 17
Net Weight 0.07 oz. (2 g)
PRINCIPAL DISPLAY PANEL - 2 g Carton - ROSA 3
ēsika
PERFECT SKIN COVERAGE CONCEALER SPF 17
Net Weight 0.07 oz. (2 g)
PRINCIPAL DISPLAY PANEL - 2 g Carton - ROSA 4
ēsika
PERFECT SKIN COVERAGE CONCEALER SPF 17
Net Weight 0.07 oz. (2 g)
PRINCIPAL DISPLAY PANEL - 2 g Carton - ROSA 5
ēsika
PERFECT SKIN COVERAGE CONCEALER SPF 17
Net Weight 0.07 oz. (2 g)
PRINCIPAL DISPLAY PANEL - 2 g Carton - ROSA 6
ēsika
PERFECT SKIN COVERAGE CONCEALER SPF 17
Net Weight 0.07 oz. (2 g)
FDA-Initiated Inactive NDC Indexing#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Titanium Dioxide | ACTIVE INGREDIENT | 15FIX9V2JP | 2 | |
| Titanium Dioxide | ACTIVE MOIETY | 15FIX9V2JP | 2 | |
| .alpha.-tocopherol acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 2 | |
| alkyl (C12-15) benzoate | INACTIVE INGREDIENT | A9EJ3J61HQ | 2 | |
| allantoin | INACTIVE INGREDIENT | 344S277G0Z | 2 | |
| ascorbyl palmitate | INACTIVE INGREDIENT | QN83US2B0N | 2 | |
| butylparaben | INACTIVE INGREDIENT | 3QPI1U3FV8 | 2 | |
| calendula officinalis flower | INACTIVE INGREDIENT | P0M7O4Y7YD | 2 | |
| carnauba wax | INACTIVE INGREDIENT | R12CBM0EIZ | 2 | |
| di-ppg-3 myristyl ether adipate | INACTIVE INGREDIENT | T32481VTXW | 2 | |
| dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 2 | |
| Ethylhexyl palmitate | INACTIVE INGREDIENT | 2865993309 | 2 | |
| ethylparaben | INACTIVE INGREDIENT | 14255EXE39 | 2 | |
| ferric oxide red | INACTIVE INGREDIENT | 1K09F3G675 | 2 | |
| ferric oxide yellow | INACTIVE INGREDIENT | EX438O2MRT | 2 | |
| ferrosoferric oxide | INACTIVE INGREDIENT | XM0M87F357 | 2 | |
| hedera helix leaf | INACTIVE INGREDIENT | ZP9XFG71A7 | 2 | |
| high density polyethylene | INACTIVE INGREDIENT | UG00KM4WR7 | 2 | |
| isobutylparaben | INACTIVE INGREDIENT | 0QQJ25X58G | 2 | |
| medium-chain triglycerides | INACTIVE INGREDIENT | C9H2L21V7U | 2 | |
| methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | 2 | |
| mica | INACTIVE INGREDIENT | V8A1AW0880 | 2 | |
| phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 2 | |
| phosphoric acid | INACTIVE INGREDIENT | E4GA8884NN | 2 | |
| polyoxyl 40 hydrogenated castor oil | INACTIVE INGREDIENT | 7YC686GQ8F | 2 | |
| polysorbate 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 2 | |
| ppg-26-buteth-26 | INACTIVE INGREDIENT | 2II1K6TZ4P | 2 | |
| propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | 2 | |
| sorbitan isostearate | INACTIVE INGREDIENT | 01S2G2C1E4 | 2 | |
| starch, corn | INACTIVE INGREDIENT | O8232NY3SJ | 2 | |
| sunflower oil | INACTIVE INGREDIENT | 3W1JG795YI | 2 | |
| vitamin a palmitate | INACTIVE INGREDIENT | 1D1K0N0VVC | 2 |
Products#
Every source-derived product name is available through these pages.
- ESIKA PERFECT SKIN COVERAGE CONCEALER SPF 17 (Beige 1) - BEIGE
- Titanium Dioxide
- Ethylhexyl palmitate
- alkyl (C12-15) benzoate
- medium-chain triglycerides
- mica
- di-ppg-3 myristyl ether adipate
- sorbitan isostearate
- high density polyethylene
- carnauba wax
- starch, corn
- sunflower oil
- phenoxyethanol
- calendula officinalis flower
- methylparaben
- dimethicone
- polyoxyl 40 hydrogenated castor oil
- polysorbate 80
- ppg-26-buteth-26
- butylparaben
- ethylparaben
- hedera helix leaf
- vitamin a palmitate
- phosphoric acid
- .alpha.-tocopherol acetate
- isobutylparaben
- propylparaben
- allantoin
- ascorbyl palmitate
- ferric oxide yellow
- ferric oxide red
- ferrosoferric oxide
- ESIKA PERFECT SKIN COVERAGE CONCEALER SPF 17 (Beige 2) - BEIGE
- ESIKA PERFECT SKIN COVERAGE CONCEALER SPF 17 (Beige 3) - BEIGE
- ESIKA PERFECT SKIN COVERAGE CONCEALER SPF 17 (Beige 4) - BEIGE
- ESIKA PERFECT SKIN COVERAGE CONCEALER SPF 17 (Beige 5) - BEIGE
- ESIKA PERFECT SKIN COVERAGE CONCEALER SPF 17 (Beige 6) - BEIGE
- ESIKA PERFECT SKIN COVERAGE CONCEALER SPF 17 (Rosa 1) - PINK
- ESIKA PERFECT SKIN COVERAGE CONCEALER SPF 17 (Rosa 2) - PINK
- ESIKA PERFECT SKIN COVERAGE CONCEALER SPF 17 (Rosa 3) - PINK
NDC Codes#
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SUSPENSION / SOFT TISSUE | 4 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | DROPS / AURICULAR (OTIC) | 0.01 %w/w | ||
| starch, corn | STARCH, CORN | O8232NY3SJ | CONCENTRATE / ORAL | NA | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | CAPSULE, EXTENDED RELEASE / ORAL | 2 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION / INTRAVENOUS | 4680 mg | ||
| phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | 10 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | ELIXIR / ORAL | 2.5 mg/15ml | ||
| ferric oxide yellow | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET / ORAL | 24 mg | ||
| butylparaben | BUTYLPARABEN | 3QPI1U3FV8 | LIQUID / TOPICAL | 0.02 %w/w | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUSPENSION / ORAL | 206 mg | ||
| phosphoric acid | PHOSPHORIC ACID | E4GA8884NN | CREAM / VAGINAL | 0.56 %w/w | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | POWDER / ORAL | NA | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | CREAM / TOPICAL | NA | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 0.4 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | OINTMENT / OPHTHALMIC | 0.01 %w/w | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | POWDER / ORAL | NA | ||
| phosphoric acid | PHOSPHORIC ACID | E4GA8884NN | INJECTION / INTRAMUSCULAR | ADJ PH | ||
| phosphoric acid | PHOSPHORIC ACID | E4GA8884NN | CREAM / TOPICAL | 13 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.02 %w/v | ||
| ferric oxide yellow | FERRIC OXIDE YELLOW | EX438O2MRT | POWDER / RESPIRATORY (INHALATION) | 0.04 mg | ||
| ethylparaben | ETHYLPARABEN | 14255EXE39 | POWDER, FOR SOLUTION / ORAL | 13 mg | ||
| phosphoric acid | PHOSPHORIC ACID | E4GA8884NN | TABLET / ORAL | 0.04 mg | ||
| ferric oxide yellow | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, FILM COATED / ORAL | 6 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 0.8 mg | ||
| butylparaben | BUTYLPARABEN | 3QPI1U3FV8 | SUSPENSION / ORAL | 12 mg | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | POWDER, FOR SUSPENSION / ORAL | 3390 mg/5ml | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | ENEMA / RECTAL | 0.02 %w/w | ||
| ferric oxide yellow | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET / SUBLINGUAL | 1 mg | ||
| polyoxyl 40 hydrogenated castor oil | POLYOXYL 40 HYDROGENATED CASTOR OIL | 7YC686GQ8F | SOLUTION / ORAL | 3240 mg | ||
| ferric oxide yellow | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, ORALLY DISINTEGRATING / ORAL | 2 mg | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | GEL / TOPICAL | 12 mg | ||
| starch, corn | STARCH, CORN | O8232NY3SJ | TABLET / SUBLINGUAL | 409 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SUSPENSION / ORAL | 75 mg | ||
| polyoxyl 40 hydrogenated castor oil | POLYOXYL 40 HYDROGENATED CASTOR OIL | 7YC686GQ8F | CAPSULE, COATED / ORAL | 101.25 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | DROPS / NASAL | 14 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / RESPIRATORY (INHALATION) | 0.03 %w/w | ||
| phosphoric acid | PHOSPHORIC ACID | E4GA8884NN | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 6 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SOLUTION / ORAL | 126 mg | ||
| phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| ferric oxide yellow | FERRIC OXIDE YELLOW | EX438O2MRT | FILM / BUCCAL | 0.27 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | TABLET, COATED / ORAL | 0.8 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUPPOSITORY / RECTAL | 72.15 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INFILTRATION | 0.35 mg | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, ORALLY DISINTEGRATING / ORAL | 2 mg | ||
| high density polyethylene | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | SYSTEM / TRANSDERMAL | NA | ||
| high density polyethylene | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | FILM, EXTENDED RELEASE / TRANSDERMAL | 85 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / RECTAL | 1808 mg | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SUSPENSION / ORAL | 10170 mg | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, COATED / ORAL | 207.5 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | POWDER, FOR SUSPENSION / ORAL | 396 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | ENEMA / RECTAL | 0.01 %w/v | ||
| starch, corn | STARCH, CORN | O8232NY3SJ | TABLET, ORALLY DISINTEGRATING / ORAL | 100 mg | ||
| butylparaben | BUTYLPARABEN | 3QPI1U3FV8 | CAPSULE / ORAL | NA | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / AURICULAR (OTIC) | NA | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | CONCENTRATE / ORAL | 2.5 mg/5ml | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | FILM / BUCCAL | 0.22 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SYRUP / ORAL | 40 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION/ DROPS / OPHTHALMIC | 0.01 %w/v | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | FILM / BUCCAL | 1 mg | ||
| starch, corn | STARCH, CORN | O8232NY3SJ | DROPS / ORAL | NA |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 334e32a4-c3a9-e37d-e063-6294a90ad6cf | d59348d1-8c8b-403b-bc10-4e5fade9ca79 | 2025-04-21 | Warnings | d59348d1-8c8b-403b-bc10-4e5fade9ca79 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.